7506 ORAL Up to 6 years follow-up of patients receiving imatinib mesylate (Glivec) to treat unresectable or metastatic gastrointestinal stromal tumors (GISTs)
Joensuu, H, Demetri, G.D, Heinrich, M.C, Eisenberg, B.L, Fletcher, J.A, Corless, C.L, Fletcher, C.D, Blanke, C, Heintz, D, von Mehren, M
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
2051 A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger
Freedman, G.M., Fowble, B.L., Hanlon, A.L., Myint, M.A., Hoffman, J.P., Sigurdson, E.R., Eisenberg, B.L., Goldstein, L.J., Fein, D.A.
Published in International journal of radiation oncology, biology, physics (1997)
Published in International journal of radiation oncology, biology, physics (1997)
Get full text
Journal Article
19 The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor positive early stage breast cancer
Fowble, B., Fein, D.A., Hanlon, A.L., Eisenberg, B.L., Hoffman, J.P., Sigurdson, E.R., Daly, M.B., Goldstein, L.J.
Published in International journal of radiation oncology, biology, physics (1995)
Published in International journal of radiation oncology, biology, physics (1995)
Get full text
Journal Article